Call for Abstract

Abstracts submission is now closed

The EHC 2017 Scientific Committee invites you to submit abstracts as either oral or poster presentations. Abstracts will be peer-reviewed, and accepted submissions will be published in the conference proceedings. Submissions are only accepted online.

  • Abstract submission opens for Oral and Poster Presentations
  • Abstract Submissions will be divided into separate themes

Guidelines for submitting an abstract
The scientific committee will accept abstracts based on their relevance and quality, structure, content and degree of innovation.

Abstract  Topics

  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Bone Marrow Failure
  • Chronic Lymphocytic Leukemia and Related Disorders
  • Chronic Myelogenous Leukemia
  • Coagulation Disorders
  • Cytogenics and Molecular Diagnostics
  • Drug Resistance and Pharmacology
  • Genomics and Proteomics
  • Hemostasis & Thrombosis
  • Hodgkin Lymphoma
  • Infections in the Immune Compromised Host
  • Iron Overload
  • ITP
  • Lymphoma
  • MDS and Bone Marrow Failure Syndromes including PNH
  • Myeloma
  • Myeloma and other Monoclonal Gammopathies
  • Myeloproliferative Disorders
  • Non Hodgkin Lymphoma
  • Novel Therapeutics, Targeted Therapies and Gene Therapy
  • Pediatric Haematology
  • Platelets and Thrombocytopenia
  • Quality & Patient Safety in Hematology & Hematopathology
  • Quality of Life, Palliative Care and Ethics
  • Red Blood Cells and Iron; Physiology and Disease
  • Stem Cell Transplantation
  • Training & Education in Hematology and Hematopathology
  • Transfusion Medicine

Structure of the Abstract

The structure of the abstract should be as follows:

 Background and Purpose

Methodology

Results and Discussion

 Conclusions

  • Please note that a maximum of 300 words is permitted. The titles and the names of the authors are excluded from this number and have to be entered separately. Tables should not be included in the abstract body.
  • The methodology section should include the type of statistical analysis done if applicable to the study.
  • Statements like “Results will be discussed” are not acceptable and may lead to a rejection of the abstract

Author Agreement

By submitting the abstract, the author confirms and agrees to the following:

  • All authors approve submitting this work for presentation.
  • The authors have done the work reported in the abstract and take full responsibility for the contents
  • The authors transfer all copyright ownership of the abstract to EHC 2017.
  • The authors agree to confine their presentation to information in the abstract.
  • At least one author will be available to present the abstract if selected for the program.
  • The author will immediately notify the EHC 2017 Scientific Committee if they are unable to make a presentation or if the presenting author must be changed.
  • The authors guarantee that clinical studies and any animal tests have proceeded with the official permission from the proper authorities.
  • All presenters will be responsible for their own registration fees, hotel and travel expenses. We regret that we cannot waive registration fees or cover expenses for any oral or poster presenters.